NCT01325142 Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer Status COMPLETED Phase N/A
NCT01323517 Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity Status COMPLETED Phase PHASE2
NCT01323309 Trial of Individual Psychosocial Interventions for Cancer Patients Status COMPLETED Phase N/A
NCT01312857 Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01300429 Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene Locus Status COMPLETED Phase N/A
NCT01297452 BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01297231 Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI Status WITHDRAWN Phase N/A
NCT01294670 Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT01276041 Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer Status COMPLETED Phase PHASE2
NCT01275404 Therapy for Erectile Dysfunction Adaptation of ACT for Compliance With an Erectile Rehabilitation Program Status COMPLETED Phase NA
NCT01273896 Open-label Study of STA-9090 for Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT01269593 PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT01268579 Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma Status COMPLETED Phase NA
NCT01266096 PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study Status ACTIVE_NOT_RECRUITING Phase NA
NCT01266083 WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE2
NCT01266018 Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT01262222 Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events Status COMPLETED Phase N/A
NCT01262040 Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive Status COMPLETED Phase NA